First Time Loading...
S

ST Pharm Co Ltd
KOSDAQ:237690

Watchlist Manager
ST Pharm Co Ltd
KOSDAQ:237690
Watchlist
Price: 91 200 KRW -1.51% Market Closed
Updated: May 11, 2024
Section:
 

Relative Value

The Relative Value of one ST Pharm Co Ltd stock under the Base Case scenario is 188 693.55 KRW. Compared to the current market price of 91 200 KRW, ST Pharm Co Ltd is Undervalued by 52%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
188 693.55 KRW
Undervaluation 52%
Relative Value
Price
S
Worst Case
Base Case
Best Case

Valuation Multiples

6
P/S
P/S
Price to Sales
6
vs History
60
vs Industry
31
Median 3Y
7.2
Median 5Y
6.5
Industry
4
Forward
5.3
More Details
87.6
P/E
P/E
Price to Earnings
87.6
vs History
31
vs Industry
3
Median 3Y
89.7
Median 5Y
61.1
Industry
31.1
Forward
45.6
More Details
1 321.2
P/OCF
P/OCF
Price to OCF
1 321.2
vs History
6
vs Industry
100
Median 3Y
219.6
Median 5Y
47
Industry
23.7
More Details
36.1
P/FCFE
P/FCFE
Price to FCFE
36.1
vs History
1
vs Industry
19
Median 3Y
-32.9
Median 5Y
-24.4
Industry
28.7
More Details
4.5
P/B
P/B
Price to Book Value
4.5
vs History
44
vs Industry
21
Median 3Y
4.9
Median 5Y
4.4
Industry
2.6
More Details
6.3
EV/S
EV/S
Enterprise Value to Sales
6.3
vs History
50
vs Industry
29
Median 3Y
7.4
Median 5Y
6.5
Industry
3.9
Forward
5.6
More Details
16.1
EV/GP
EV/GP
Enterprise Value to Gross Profit
16.1
vs History
60
vs Industry
19
Median 3Y
20.5
Median 5Y
20.5
Industry
8
More Details
32
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
32
vs History
46
vs Industry
11
Median 3Y
43.3
Median 5Y
29.1
Industry
17.5
Forward
26.6
More Details
54
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
54
vs History
44
vs Industry
6
Median 3Y
77.6
Median 5Y
38.5
Industry
22.8
Forward
40
More Details
1 392.5
EV/OCF
EV/OCF
Enterprise Value to OCF
1 392.5
vs History
6
vs Industry
0
Median 3Y
218.1
Median 5Y
46.1
Industry
21.9
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
Median 3Y
-39
Median 5Y
-32.5
Industry
27.9
More Details
3.2
EV/IC
EV/IC
Enterprise Value to IC
3.2
vs History
47
vs Industry
32
Median 3Y
3.4
Median 5Y
3.2
Industry
2.4
More Details

Multiples Across Competitors

Competitors Multiples
ST Pharm Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
KR
ST Pharm Co Ltd
KOSDAQ:237690
1.7T KRW 6 87.6 32 54
US
Thermo Fisher Scientific Inc
NYSE:TMO
229.3B USD 5.4 38.2 23.5 34.5
US
Danaher Corp
NYSE:DHR
187.7B USD 4.3 23.3 16.9 20.8
US
Agilent Technologies Inc
NYSE:A
43.9B USD 6.5 35.5 28.3 34.1
US
IQVIA Holdings Inc
NYSE:IQV
42.5B USD 2.8 31.3 16.9 26.2
CH
Lonza Group AG
SIX:LONN
37.9B CHF 5.6 58 19.9 29.2
KR
Samsung Biologics Co Ltd
KRX:207940
56T KRW 15.2 65.3 34.4 49.6
US
Mettler-Toledo International Inc
NYSE:MTD
32.5B USD 8.6 41.2 28.5 31.7
US
West Pharmaceutical Services Inc
NYSE:WST
26.6B USD 9.1 46.7 32.5 39.4
IE
ICON PLC
NASDAQ:ICLR
26.1B USD 3.2 38.2 17.2 26.4
US
Waters Corp
NYSE:WAT
20.8B USD 7.2 34.5 23.2 28.6

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 136,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.